Proficio Capital Partners LLC acquired a new position in Piper Sandler Companies (NYSE:PIPR – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC.

Piper Sandler Companies Trading Up 0.8 % Shares of PIPR stock opened at $254.06 on Friday. Piper Sandler Companies has a 1 year low of $183.58 and a 1 year high of $351.80. The firm’s 50 day ...

Piper Sandler demonstrated resilience in its financial performance for the fourth quarter of 2024, reporting adjusted earnings per share (EPS) of $4.80, surpassing both JMP Securities’ estimate ...

Investing.com -- Piper Sandler analysts believe a U.S. government shutdown is unlikely as momentum builds for a temporary funding measure that would keep operations running through September 30 ...

On Friday, JMP Securities analyst Devin Ryan maintained a Market Perform rating for Piper Sandler (NYSE: PIPR), a leading player in the middle markets. According to InvestingPro data, the $4.47 ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is excited to announce a new office opening in Zurich, Switzerland led by experienced industry veterans, Alex Molloy, Vincenzo Pescuma ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is excited to announce a new office opening in Zurich, Switzerland led by experienced industry veterans, Alex Molloy, Vincenzo ...

NEW YORK, February 26, 2025--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Mary Stone as a managing director and co-head ...

ZURICH--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is excited to announce a new office opening in Zurich, Switzerland led by experienced industry veterans ...

Piper Sandler (PIPR) announced a new office opening in Zurich, Switzerland. Effectively assess a stock's risks and opportunities with a clear breakdown of its positive and negative factors.

In a report released today, Allison Bratzel from Piper Sandler maintained a Hold rating on Blueprint Medicines (BPMC – Research Report), with a price target of $119.00. The company’s shares ...

Piper Sandler analysts presented their actionable stock recommendations, as the market engages in extreme bearish sentiment over concerns of economic growth, tariffs, and other policies.